Tempus
With Tempus Test Integration, CureMD Wants Genomics to Inform Oncology Clinical Decision Support
Premium
The specialty EHR vendor is building a two-way interface with Tempus as a model for incorporating genomic test ordering and results return into oncology workflows.
Tempus to Integrate Genomic Test Ordering Into CureMD's Oncology EHR
The multiyear partnership will eventually enable the return of results as discrete data through the CureMD EHR to inform clinical decision support.
In Brief This Week: Thermo Fisher Scientific; Quest, Danaher; and More
News items for the week of Aug. 14, 2023.
Tempus, AstraZeneca Partner to Study NSCLC Biology in GEMINI Trial
Researchers will molecularly profile patients' tumors and track over three years how their tumor biology changes as their disease progresses and they receive treatment.
Tempus, TScan Therapeutics Partner on CDx for T-Cell Receptor Therapy in Solid Tumors
The companies will collaborate to develop a companion diagnostic to support TScan's screening protocol for its Phase 1 solid tumor clinical trial.